1-167821380-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_018417.6(ADCY10):c.4286+644A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.629 in 152,174 control chromosomes in the GnomAD database, including 30,944 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.63 ( 30944 hom., cov: 33)
Consequence
ADCY10
NM_018417.6 intron
NM_018417.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.269
Publications
4 publications found
Genes affected
ADCY10 (HGNC:21285): (adenylate cyclase 10) The protein encoded by this gene belongs to a distinct class of adenylyl cyclases that is soluble and insensitive to G protein or forskolin regulation. Activity of this protein is regulated by bicarbonate. Variation at this gene has been observed in patients with absorptive hypercalciuria. Alternatively spliced transcript variants encoding different isoforms have been observed. There is a pseudogene of this gene on chromosome 6. [provided by RefSeq, Jul 2014]
ADCY10 Gene-Disease associations (from GenCC):
- hypercalciuria, absorptive, 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- idiopathic inherited hypercalciuriaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.763 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ADCY10 | NM_018417.6 | c.4286+644A>G | intron_variant | Intron 30 of 32 | ENST00000367851.9 | NP_060887.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.629 AC: 95592AN: 152056Hom.: 30903 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
95592
AN:
152056
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.629 AC: 95695AN: 152174Hom.: 30944 Cov.: 33 AF XY: 0.623 AC XY: 46350AN XY: 74396 show subpopulations
GnomAD4 genome
AF:
AC:
95695
AN:
152174
Hom.:
Cov.:
33
AF XY:
AC XY:
46350
AN XY:
74396
show subpopulations
African (AFR)
AF:
AC:
31960
AN:
41504
American (AMR)
AF:
AC:
9381
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
2058
AN:
3470
East Asian (EAS)
AF:
AC:
1951
AN:
5166
South Asian (SAS)
AF:
AC:
2069
AN:
4830
European-Finnish (FIN)
AF:
AC:
6259
AN:
10588
Middle Eastern (MID)
AF:
AC:
155
AN:
294
European-Non Finnish (NFE)
AF:
AC:
40091
AN:
68006
Other (OTH)
AF:
AC:
1263
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1798
3596
5395
7193
8991
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1587
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.